PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling.

Li, Qing; Wang, Su-Jie; Wang, Wen-Jia; Ye, Yu-Cai; Ling, Ya-Qin; Dai, Ya-Fei

Li, Qing; Wang, Su-Jie; Wang, Wen-Jia; Ye, Yu-Cai; Ling, Ya-Qin; Dai, Ya-Fei.

Afiliación

Li Q; Institute of Pathophysiology, College of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Wang SJ; Institute of Pathophysiology, College of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Wang WJ; Clinical Laboratory, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China.
Ye YC; Institute of Pathophysiology, College of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Ling YQ; Key Laboratory of Ethnomedicine (Minzu University of China), Ministry of Education, Beijing, China.
Dai YF; Institute of Pathophysiology, College of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

Transl Cancer Res ; 12(3): 461-472, 2023 Mar 31.

Article en En | MEDLINE | ID: mdl-37033362

Palabras clave

P21-activated kinase 4 (PAK4); autophagy; cell cycle; mammalian target of rapamycin (mTOR); p53

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google